Peer Support for Polysubstance Abuse
(PRISM Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in an underserved, rural area. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on improving adherence to medication for opioid use disorder and reducing polysubstance use.
What data supports the effectiveness of the treatment Peer-Delivered Behavioral Activation for polysubstance abuse?
Research suggests that peer recovery specialists, who have personal experience with substance use, can effectively deliver behavioral activation (a therapy that helps people engage in positive activities) to support individuals in methadone treatment and reduce problematic substance use. This approach has shown promise in improving treatment retention and is considered acceptable and appropriate in underserved communities.12345
Is peer-delivered behavioral activation safe for humans?
How is Peer-Delivered Behavioral Activation different from other treatments for polysubstance abuse?
Peer-Delivered Behavioral Activation is unique because it involves trained peer recovery specialists, who have personal experience with substance use and recovery, delivering the treatment. This approach not only provides behavioral activation, which helps individuals engage in positive activities to improve their mood, but also leverages the shared experiences of peers to enhance support and retention in treatment.12357
Research Team
Sarah Kattakuzhy, MD
Principal Investigator
University of Maryland, Baltimore
Jessica F Magidson, PhD
Principal Investigator
University of Maryland, College Park
Eligibility Criteria
This trial is for adults over 18 with opioid use disorder and polysubstance use in a rural area, who have struggled to stick to their medication plan or haven't refilled their pharmacy prescription recently. It's not for those with untreated severe mental health issues or pregnant individuals.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a peer-delivered behavioral activation intervention to improve adherence to medication for opioid use disorder and reduce polysubstance use
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Peer-Delivered Behavioral Activation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, College Park
Lead Sponsor
University of Maryland, Baltimore
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Weill Medical College of Cornell University
Collaborator